جامعة المعرفة
المصدر المعتمد للمعلومات البحثية والمخرجات هو قاعدة بيانات سكوبس (Elsevier Scopus) مع تدقيق بيانات الباحثين من عمادة البحث العلمي.

Research outputs

المخرجات البحثية

مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.

48 مُخرَج نتائج البحث عن «Arthritis»

مقالمفتوح (مستودع)2026

Unraveling the Anti‐Arthritic Potential of Bioactive Compounds From Melaleuca alternifolia Oil: Integrated In Vivo, Molecular Docking, and Network Pharmacology Insights

Food Science & Nutrition · مجلد 14 (9) · e72328-e72328

ABSTRACT Rheumatoid arthritis (RA) is a chronic inflammatory condition that affects millions of people globally, often leading to morbidity. Recent research highlights the potential of natural products in managing arthritis symptoms and modifying disease progression. Among these, Melaleuca alternifolia oil (MAO) has emerged as a promising therapeutic option due to its anti‐inflammatory and analgesic properties. A total of 36 Sprague–Dawley rats weighing between 200 and 220 g were divided into six groups ( n = 6). On day 0, arthritis was induced by CFA. On day 8, treatment started and lasted till day 28. Paw edema and arthritic score were measured. Moreover, hematological, histological, and biochemical parameters were evaluated. The mRNA expression levels of anti‐inflammatory cytokine IL‐4 and pro‐inflammatory cytokines such as TNF‐α, IL‐6, NF‐κB, and IL‐1β were measured using real‐time polymerase chain reaction (qPCR). ELISA was used to detect PGE2 levels. Network pharmacology was used to evaluate the hub genes between the phytocompounds and rheumatoid arthritis. Molecular docking and scoring calculations were done for the top matched hub genes for moderate confirmations between phytocompounds and targets. GC–MS analysis was also performed to identify potential anti‐inflammatory constituents present in the plant oil. Treatment with MAO effectively reduced paw edema and swelling. Histopathological examinations demonstrated significant improvement in the treatment groups. Biochemical parameters such as creatinine, urea, alanine aminotransferase (ALT), and alkaline phosphatase (ALP) did not significantly alter, and hematological parameters such as red blood cells (RBC), white blood cells (WBC), hemoglobin (Hb), and platelet count were restored in the treated group. The mRNA expression of anti‐inflammatory cytokines, including IL‐4, was upregulated, and pro‐inflammatory biomarkers such as TNF‐α, IL‐1β, IL‐6, and NF‐κB were significantly downregulated in the arthritic control group. Furthermore, treatment with MAO significantly reduced PGE2 levels. Network pharmacology indicated the hub genes and several biological processes, molecular functions, cellular components, and KEGG pathways that are involved in rheumatoid arthritis. Molecular docking was performed against hub genes such as AKT1, BCL‐2, MAPK3, and MMP9 that are involved in various pro‐inflammatory cytokine formation and pathophysiology of rheumatoid arthritis. GC–MS analysis of the plant's oil revealed the presence of numerous anti‐inflammatory and antirheumatic phytochemicals. MAO possesses considerable anti‐arthritic properties by downregulating pro‐inflammatory biomarkers such as IL‐1β, NF‐κB, IL‐6, TNF‐α, and upregulating anti‐inflammatory IL‐4. Further investigations are needed to explore its potential as a natural therapeutic option for treating RA.

tea tree oilrheumatoid arthritisanti-inflammatory activityCFA-induced arthritis
مراجعةوصول مفتوح2026

Neuromuscular Electrical Stimulation for Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials Evaluating Pain, Disability, Muscle Strength, and Functional Performance

Orthopedic Reviews · مجلد 18 · 168252-168252

Background: Neuromuscular electrical stimulation (NMES) is widely used in the rehabilitation of knee osteoarthritis (KOA) to improve quadriceps activation and counteract arthrogenic muscle inhibition. However, randomized controlled trials (RCTs) have reported inconsistent findings, and the overall clinical effectiveness of NMES across key patient outcomes remains uncertain. Objective: To evaluate the effects of NMES, administered alone or in combination with exercise, on pain, self-reported disability, quadriceps muscle strength, and functional performance in adults with KOA, and to explore whether treatment effects differ according to comparator intervention. Methods: A systematic review and meta-analysis of RCTs was conducted according to PRISMA 2020. PubMed/MEDLINE, Embase, Scopus, Web of Science, and CENTRAL were searched from inception to April 20, 2026. Random-effects meta-analyses were performed using restricted maximum likelihood estimation. Prespecified subgroup and sensitivity analyses were undertaken, and risk of bias was assessed using the Cochrane RoB 2 tool. Results: Eight unique RCTs (10 publications) were included. Overall, NMES did not significantly improve pain, self-reported disability, quadriceps strength, or six-minute walk distance compared with pooled comparator interventions. A significant improvement was observed for Timed Up and Go performance, although this estimate was largely driven by a single trial. Prespecified subgroup analyses demonstrated that treatment effects differed according to comparator intervention. NMES combined with exercise resulted in greater pain reduction than exercise alone, whereas no consistent advantage was observed when NMES was compared with alternative conservative interventions. Most trials were judged to have low risk of bias or some concerns. Conclusions: NMES does not appear to provide consistent clinical benefits across all rehabilitation settings for KOA. Rather, its effectiveness depends on the therapeutic context in which it is delivered, with the greatest benefit observed when used as an adjunct to structured exercise rather than as a stand-alone intervention. Larger, methodologically rigorous RCTs using standardized stimulation protocols are required to define the patients most likely to benefit.

neuromuscular electrical stimulationknee osteoarthritisquadriceps strengtharthrogenic muscle inhibition
مراجعةوصول مفتوح2026

Bone Mineral Density Changes and Metabolic Risk Factors in Patients with Rheumatoid Arthritis on Long-Term Therapy: A Narrative Review

International Journal of Clinical and Medical Research · مجلد 3 (1) · 22-26

Rheumatoid Arthritis (RA) is a chronic systemic inflammatory disease associated with progressive joint damage and important extra-articular complications, including osteoporosis, reduced Bone Mineral Density (BMD), fragility fractures, metabolic syndrome, insulin resistance, dyslipidemia, sarcopenia and cardiovascular disease. Chronic inflammation, reduced physical activity, altered body composition, nutritional deficiencies and long-term pharmacological therapy contribute to these complications. Glucocorticoids are particularly important because prolonged exposure may reduce bone formation and adversely affect glucose and lipid metabolism, although suppression of inflammation may partially counterbalance their skeletal effects. Disease-Modifying Antirheumatic Drugs (DMARDs), particularly biologic and targeted synthetic therapies, generally improve inflammatory control and may help preserve BMD but recent evidence suggests that bone loss can persist despite effective disease control. Metabolic syndrome is also common in RA and contributes substantially to cardiovascular risk. The relationship between RA and lipid abnormalities is complex because active inflammation may suppress circulating lipid concentrations despite increased cardiovascular risk. This narrative review summarizes current evidence regarding BMD changes, osteoporosis, glucocorticoid exposure, DMARD therapy, vitamin D status, metabolic abnormalities, sarcopenia and cardiovascular risk in patients receiving long-term treatment for RA. An integrated approach combining disease control, fracture-risk assessment, BMD monitoring, glucocorticoid minimization, metabolic screening, lifestyle modification and cardiovascular risk management is essential for comprehensive long-term care.

rheumatoid arthritisbone mineral densityosteoporosisglucocorticoid-induced osteoporosis
مقالوصول مفتوح2026

Nrf2–Keap1 Signaling in Arthritis: Therapeutic Potential of Nanoparticle-Based Approaches with Special Reference to Silver Nanoparticles

International Journal of Clinical and Medical Research · مجلد 3 (1) · 34-39

Arthritis represents a heterogeneous group of inflammatory and degenerative joint disorders characterized by persistent inflammation, oxidative stress, cartilage degradation, synovial dysfunction and progressive impairment of joint integrity. Rheumatoid Arthritis (RA) and Osteoarthritis (OA), although distinct in etiology, share several pathological mechanisms involving excessive production of Reactive Oxygen Species (ROS), mitochondrial dysfunction, inflammatory cytokine activation and dysregulation of redox-sensitive signaling pathways [1-4]. The nuclear factor erythroid 2-related factor 2 (Nrf2)-Kelch-like ECH-associated protein 1 (Keap1) pathway is a major endogenous defense mechanism responsible for maintaining cellular redox homeostasis. Under basal conditions, Keap1 promotes Nrf2 degradation; however, oxidative or electrophilic stress disrupts this interaction, allowing Nrf2 to accumulate and translocate into the nucleus, where it activates antioxidant response element (ARE)-dependent genes, including heme oxygenase-1 (HO-1), NAD(P)H quinone dehydrogenase 1 (NQO1) and glutathione-related enzymes [5,6]. Increasing evidence indicates that impaired or insufficient Nrf2 activity contributes to persistent oxidative stress and inflammation in arthritic joints [1,7]. Nrf2 also interacts with major inflammatory pathways, particularly nuclear factor-kappa B (NF-κB), mitogen-activated protein kinase (MAPK) and NLRP3 inflammasome signaling [8]. Nanotechnology offers an opportunity to improve the delivery, stability, bioavailability and tissue targeting of therapeutic agents capable of modulating redox and inflammatory pathways. Among different nanomaterials, silver nanoparticles (AgNPs) have attracted considerable interest because of their antimicrobial, anti-inflammatory, antioxidant and immunomodulatory properties [9-11]. Experimental studies have demonstrated that AgNPs can reduce inflammatory cytokines, regulate NF-κB and MAPK signaling, influence macrophage polarization and alleviate inflammatory tissue injury [9,10]. In experimental RA, targeted folic-acid-modified AgNPs have demonstrated the ability to interact with inflammatory macrophages, promote macrophage apoptosis and repolarization and reduce disease severity [12]. Nevertheless, the relationship between AgNP exposure, oxidative signaling and Nrf2-Keap1 activation is complex and excessive nanoparticle-induced oxidative stress may also produce adverse biological effects. This review examines the role of the Nrf2-Keap1 pathway in arthritis, evaluates nanoparticle-based strategies for modulating redox and inflammatory mechanisms and critically discusses the therapeutic potential and safety considerations of AgNPs. Particular emphasis is placed on the potential intersection between AgNP-mediated redox regulation, Nrf2-Keap1 signaling, NF-κB inhibition, macrophage polarization and joint protection.

Nrf2/Keap1 pathwayarthritisrheumatoid arthritisosteoarthritis
مقالوصول مفتوح2026

RAD-OAEnsemble: Residual attention DenseNet with radiograph-EHR fusion and dual-stream deep feature embedding for knee osteoarthritis risk prediction

Egyptian Informatics Journal · مجلد 34 · 100929-100929

Knee osteoarthritis (OA) is a popular and progressive degenerate joint disease and require a predictor of risk at the primary stage to predict drug treatment and propose an early intervention. The current methods of deep learning are not sufficient enough to deal with integrating the heterogeneous modality component, modeling of irregular temporal follow ups, and capture of the fine grained variations of pathological types. In order to address such limitations, this paper suggests a new multimodal approach named, RAD-OAEnsemble which introduces three main innovations. First, a novel Cross Bi-modal Heterogeneous Graph Fusion Network (CBHGF-Net) is introduced for the multi-scale semantic fusion of Radiographs and Electronic Health Records (EHRs). Second, a Modified DenseNet with Multi-scale Attention Criss-Cross Blocks (MACC-Blocks) is presented to extract the anatomical features of knee OA patterns by utilizing dilated convolution, criss-cross attention, residual attention gating. Third, a Dual-Stream Tranfo-Convo (DTC) Deep Temporal Embedding module is proposed that consists of a Time-Warped Convolutional Blocks and a Temporal Decay Encoded Informer for the knee OA risk prediction. The suggested approach delivered better outcomes with accuracy of 99.275%, precision of 98.175%, specificity of 99.165%, sensitivity of 98.95%, and F1-score of 98.175% in having considerably a low rate of false positives (1.875%) and false negatives (2.175%). The findings support the relevance of the suggested framework in providing resilient, time-sensitive, and explainable OA progression predictions by multimodal combination and high-fidelity feature learning.

knee osteoarthritismultimodal fusionDenseNetattention mechanism
مقالوصول مفتوح20254استشهاد· Semantic Scholar

Acetyl-11-keto-beta-boswellic acid ameliorates monosodium iodoacetate-induced osteoarthritis in rats: implications of HMGB1/TLR4/NF-κB and Nrf2/HO-1

Frontiers in Pharmacology · مجلد 16 · 1694803-1694803

Introduction: Osteoarthritis (OA) is a prevalent joint disorder marked by chronic inflammation and degradation of cartilage. The shielding effect of 3-O-acetyl-11-keto-β-boswellic acid (AKBA) has been confirmed in many inflammatory disorders. However, the full underlying mechanistic perspective of AKBA against OA remains unexplored. Thus, the objective of this work is to identify additional unexamined modulatory signals of AKBA against monosodium iodoacetate (MIA)-induced OA and the early prevention of irreversible cartilage damage. Methods: Male Wistar rats were allotted into three groups (n = 9): sham, MIA-OA, and MIA + AKBA250. Three mg of MIA was injected intra-articularly into the right knee joints of rats to induce OA on day 0. All treatments were given orally, daily, starting on the 3rd day after MIA injection and continuing until the 14th day of the experiment. Results: AKBA250 treatment alleviated edema completely, achieving nearly basal records of the right knee diameter. AKBA250 treatment enhanced macroscopic and microscopic findings and normalized the modified Mankin and OARSI scoring system. Moreover, AKBA restored cartilage matrix homeostasis by suppressing the catabolic enzyme matrix metalloproteinase-13 (MMP-13), upregulating tissue inhibitor of metalloproteinase-1 (TIMP-1) and the chondrogenic marker SRY-box transcription factor 9 (SOX9), and reducing the serum level of the cartilage degradation biomarker C-telopeptide of type II collagen (CTX-II). The contents of high-mobility group box 1 (HMGB1), toll-like receptor 4 (TLR4), nuclear factor-kappa B (NF-κB), and tumor necrosis factor-α (TNF-α) were substantially suppressed in the AKBA250-treated group. AKBA250 significantly boosted the nuclear factor erythroid-2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) levels and restored the oxidant/antioxidant equilibrium disrupted by MIA. In addition, AKBA250 prominently curbed the protein expression of p-RIPK1, p-RIPK3, and p-MLKL. Furthermore, AKBA250 exhibited downregulation of miR-34a-5p and miR-146a expressions. Conclusion: Together, AKBA demonstrated a protective function in OA by inhibiting inflammatory signaling through the HMGB1/TLR4/NF-κB pathway, augmenting the cytoprotective Nrf2/HO-1 pathway, and regulating necroptosis signaling cascades.

osteoarthritis3-O-acetyl-11-keto-β-boswellic acidboswellic acidsmonoiodoacetate-induced osteoarthritis
مقالمفتوح (مستودع)20251استشهاد

Public Awareness of Rheumatoid Arthritis as a Genetically Influenced Autoimmune Disease: A Population-Based Study in Riyadh, Saudi Arabia

Genetics and Molecular Research · مجلد 24 (4)

This cross-sectional study assessed public awareness of rheumatoid arthritis (RA) and its risk factors among 537 adults in Riyadh, Saudi Arabia in 2022. Using a structured questionnaire, the researchers evaluated participants' general knowledge about RA, awareness of signs and symptoms, and lifestyle practices. Results revealed significant knowledge deficits, with 67.6% of participants demonstrating inadequate general knowledge about RA and 58.8% showing inadequate understanding of its signs and symptoms. Physical exercise practices were found to be highly inadequate among 81.2% of participants. Although no significant associations were found between demographic characteristics (gender, education, occupation, nationality, BMI) and general knowledge, a significant relationship was observed between age and knowledge of signs and symptoms (p=0.025), with participants over 40 years showing better awareness. The findings highlight the need for enhanced public education programs about RA, particularly targeting individuals in high-risk age groups. This research underscores the importance of developing comprehensive awareness initiatives to improve early recognition, management, and quality of life outcomes for individuals with RA in Saudi Arabia.

rheumatoid arthritispublic awarenessgenetic susceptibilityautoimmune disease
مقالوصول مفتوح2025

CD209 gene polymorphism and its clinical correlation with susceptibility to rheumatoid arthritis among Egyptian patients: A case-control study

Rheumatology and Immunology Research · مجلد 6 (4) · 220-231

Abstract Background and Objectives Certain genetic traits increase the likelihood of developing rheumatoid arthritis (RA); nevertheless, the association between RA and polymorphisms in the CD209 gene is ambiguous. This study sought to investigate the correlation between RA susceptibility and the CD209 single nucleotide polymorphisms rs4804803 (AG) and rs735239 (AG) within the Egyptian population. Methods This case-control study was conducted between January and October 2024 and included 108 participants. Of these, 54 patients were diagnosed with RA according to the 2010 classification criteria of the American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR). Two CD209 promoter regions rs4804803 (-336A/G) and rs735239 (-871A/G) were genotyped for single nucleotide polymorphisms (SNPs) using multiplex polymerase chain reaction (PCR) and double amplification refractory system (dARMS). Results Patients with RA showed significantly higher frequencies of the CD209 rs4804803 SNP in the AG ( P = 0.036) and GG ( P = 0.006) genotypes compared to controls. Under the dominant paradigm, those with CD209 rs4804803 genotypes (AG+GG) had an elevated risk of RA ( P = 0.003). In recessive inheritance model, RA patients had a greater frequency of the rs4804803 GG polymorphism than controls ( P = 0.017). Additionally, relative to the A allele, the rs4804803 G allele raised the risk of RA ( P = 0.001). No significant difference was observed between the two groups in the distribution of rs735239 genotypes. However, RA patients carrying the rs4804803 AG or GG genotypes exhibited significantly higher rates of morning stiffness ( P = 0.001) and elevated CRP levels ( P = 0.009). Conclusions This work highlights the significant role of the CD209 rs4804803 polymorphism, particularly the G allele, in the elevated susceptibility to RA among Egyptians.

rheumatoid arthritisDC-SIGNCLEC4Dsingle nucleotide polymorphisms
مقالوصول مفتوح2025

Neuromuscular Adaptations Following Balance-Oriented Rehabilitation in Stroke Patients with Knee Osteoarthritis.

Clinical Medicine And Health Research Journal · مجلد 5 (03) · 1310-1312

Background: Stroke and knee osteoarthritis (OA) are prevalent conditions that significantly impair lower limb function and mobility. While stroke rehabilitation focuses on neuroplastic recovery, the presence of OA may limit neuromuscular gains due to pain, joint stiffness, and disuse. Understanding the neuromuscular adaptations from balance-focused rehabilitation in this dual-diagnosis population is essential. Objective: To evaluate neuromuscular adaptations, particularly in hip stabilizers, and improvements in postural control and gait following an 8-week balance-oriented rehabilitation program in stroke patients with knee OA. Methods: A quasi-experimental study was conducted with 18 post-stroke individuals (mean age 64.3 ± 6.1 years) diagnosed with mild-to-moderate knee OA. Participants completed an 8-week intervention consisting of proprioceptive, static and dynamic balance exercises, and hip/core strengthening. Outcomes included hip muscle strength (Manual Muscle Testing), Functional Reach Test (FRT), Timed Up and Go (TUG), Center of Pressure (COP) metrics (Pedalo®-Sensamove), gait parameters (velocity, stride length, cadence), and EMG activation of the gluteus medius and vastus medialis. Data were analyzed using paired t-tests and Pearson correlation. Results: Significant improvements were observed post-intervention in hip flexor strength (p=0.004), FRT (p=0.008), and anterior COP range (p=0.013). EMG amplitude (RMS) of gluteus medius increased by 24.6% during stance tasks (p=0.002). Improvements in EMG activity were moderately correlated with better TUG and FRT scores. Conclusion: Balance-oriented rehabilitation induces favorable neuromuscular adaptations in stroke patients with OA. Strengthening hip stabilizers and enhancing postural control can mitigate the combined impairments of stroke and OA.

strokeknee osteoarthritisneuromuscular adaptationpostural control
مقالوصول مفتوح2025

Impact of Strength and Balance Training on Functional Mobility in Stroke Patients with Knee Osteoarthritis.

Clinical Medicine And Health Research Journal · مجلد 5 (03) · 1307-1309

Background: Stroke survivors with comorbid knee osteoarthritis (OA) often experience compounded impairments in mobility, balance, and muscle strength. Strength and balance training is an essential rehabilitation strategy to restore function. Objective: This study aimed to examine the effects of an 8-week progressive strength and balance training program on hip strength, dynamic balance, and functional mobility in stroke survivors with knee OA. Methods: A randomized controlled trial was conducted involving 37 post-stroke patients (Group 1: without OA, n=20; Group 2: with OA, n=17). Participants underwent an 8-week intervention comprising hip strengthening, core stability, balance training, and gait exercises. Hip flexor/extensor strength, One Leg Stance (OLS), Functional Reach Test (FRT), Timed Up and Go (TUG), and Center of Pressure (COP) metrics were evaluated pre- and post-intervention. Data were analyzed using repeated measures ANOVA. Results: Significant improvements in hip muscle strength and balance were observed post-intervention in both groups, with a greater percentage change in Group 1. Group 2 exhibited improved but lesser gains. Time × group interaction was significant for OLS, COP range (front and back), and left hip strength (p<0.05). Conclusion: Strength and balance training significantly improved physical function in stroke survivors with and without knee OA. Although OA presence reduced the magnitude of gains, all participants benefitted, suggesting the need for individualized, progressive training programs.

stroke rehabilitationknee osteoarthritisresistance trainingbalance training
مقالمفتوح (مستودع)2025

THE EFFECTIVENESS OF PLATELET-RICH PLASMA THERAPY IN TREATING KNEE OSTEOARTHRITIS

Dialnet (Universidad de la Rioja)

Background: Knee osteoarthritis (KOA) is a prevalent degenerative joint disorder characterized by cartilage deterioration, pain, and functional impairment. Platelet-rich plasma (PRP) therapy has emerged as a promising regenerative treatment due to its potential to modulate inflammation and promote tissue repair. This study aimed to evaluate the clinical efficacy of PRP in patients with KOA, focusing on pain reduction, functional improvement, and structural changes over a six-month period. Methods: A prospective clinical trial was conducted with 133 patients diagnosed with KOA (Kellgren-Lawrence grades 1–3). Participants received three weekly intra-articular PRP injections. Outcomes were assessed at baseline, 1, 3, and 6 months’ post-treatment using the Visual Analog Scale (VAS) for pain, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the Knee Society Score (KSS). Magnetic resonance imaging (MRI) was performed at baseline and 6 months to evaluate cartilage thickness. Statistical analysis was performed using non-parametric tests. Results: Significant improvements were observed in all outcome measures. VAS scores decreased from 7.8 ± 1.1 at baseline to 2.0 ± 1.0 at 6 months (p < 0.05) WOMAC scores improved from 65.7 ± 11.4 to 28.6 ± 7.3, and KSS scores increased from 52.6 ± 9.3 to 79.3 ± 8.9 (p < 0.05). MRI revealed modest increases in cartilage thickness, particularly in the medial compartments (0.3 mm in the femoral condyle and 0.2 mm in the tibial plateau). Conclusion: PRP therapy significantly reduced pain, improved joint function, and enhanced quality of life in KOA patients over six months. While structural changes were modest, the clinical outcomes support PRP as an effective conservative treatment for early to moderate KOA. Further research with longer follow-up and control groups is warranted to validate these findings.

platelet-rich plasmaknee osteoarthritisintra-articular injectionanalgesia
مقالمفتوح (مستودع)2025

Association Between Hip Strength and Dynamic Balance in Stroke Survivors with Coexisting Knee Osteoarthritis

International Journal of Physical Therapy Research & Practice · مجلد 4 (5) · 256-263

Background: Stroke patients often experience impaired balance and mobility, which may be exacerbated by comorbid knee osteoarthritis (OA). Hip muscle weakness is a key contributor to reduced dynamic stability in these populations. Objective: To examine the association between hip muscle strength and dynamic balance in stroke survivors with and without knee OA. Methods: This cross-sectional study included 37 post-stroke participants (20 without OA, 17 with OA). Hip flexion and extension strength were assessed using manual muscle testing (MMT). Balance was evaluated via One-Leg Stance (OLS), Center of Pressure (COP) range and sway, and the Functional Reach Test (FRT). Results: Stroke patients with OA demonstrated significantly lower hip strength and impaired balance performance compared to those without OA. Hip flexor and extensor strength on the affected side showed moderate correlations with OLS (r = 0.52), COP sway (r = 0.49), and FRT (r = 0.45). The OA group had reduced OLS time (p < 0.05) and a smaller COP range. Conclusion: Hip muscle weakness is significantly associated with compromised dynamic balance in stroke patients with knee OA, underscoring the importance of hip-focused rehabilitation strategies in this population.

hip muscle strengthdynamic balancestroke survivorsknee osteoarthritis